Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: A prospective, randomized study of Toremifene vs. tamoxifen for the treatment of premenopausal breast cancer: safety and genital symptom analysis

Fig. 2

Incidences of ovarian cysts and endometrial thickening in premenopausal women treated with tamoxifen or toremifene. a Percentage of ovarian cysts (largest diameter ≥ 2 cm); b Mean values of ovarian cysts diameters in two groups. c Percentage of endometrial thickening (endometrial thickness ≥ 8 mm) in two groups; d Mean values of endometrial thickness for patients with endometrial thickening in two groups. Abbreviation: TAM tamoxifen, TOR toremifene

Back to article page